Not all abdominal masses after colorectal cancer surgery are malignant: intra‐abdominal fibromatosis masquerading as recurrence-Reference-Cited by-同舟云学术

Not all abdominal masses after colorectal cancer surgery are malignant: intra‐abdominal fibromatosis masquerading as recurrence

Published:2019-04-21 Issue:8 Volume:21 Page:886-893
ISSN:1462-8910
Container-title:Colorectal Disease
language:en
Short-container-title:Colorectal Dis

Author:

Panagiotopoulou I. G.¹,Shah N.¹,Rowaiye B.¹,Chandrakumaran K.¹,Carr N. J.¹,Moran B.¹

Affiliation:

1. Peritoneal Malignancy Institute Basingstoke and North Hampshire Hospital Basingstoke UK

Publisher

Wiley

Subject

Gastroenterology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/codi.14626

Reference45 articles.

1. National Institute for Health and Care Excellence (NICE).Colorectal cancer: diagnosis and management (CG131) 2011.https://www.nice.org.uk/guidance/cg131(accessed September 2018).

2. Staging recurrent metastatic colorectal carcinoma with PET;Delbeke D;J Nucl Med,1997

3. Surveillance with serial serum carcinoembryonic antigen levels detect colorectal cancer recurrences in patients who are initial nonsecretors;Holt A;Am Surg,2010

4. Mesenteric fibromatosis

5. Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases;LANCET ONCOL;2020

2. PROPHYLOCHIP: no benefit of second-look surgery plus HIPEC for colorectal peritoneal metastases;The Lancet Oncology;2020-09

3. Clinicopathological characteristics, treatment, and survival outcomes of retroperitoneal desmoid-type fibromatosis;Medicine;2019-11